Masimo Co. (NASDAQ:MASI) insider Jon Coleman sold 2,000 shares of Masimo stock in a transaction dated Friday, January 18th. The stock was sold at an average price of $120.00, for a total value of $240,000.00. Following the transaction, the insider now directly owns 13,201 shares in the company, valued at $1,584,120. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Jon Coleman also recently made the following trade(s):
- On Thursday, January 31st, Jon Coleman sold 2,000 shares of Masimo stock. The shares were sold at an average price of $125.00, for a total value of $250,000.00.
- On Tuesday, January 15th, Jon Coleman sold 2,000 shares of Masimo stock. The shares were sold at an average price of $115.00, for a total value of $230,000.00.
Masimo stock opened at $128.43 on Thursday. Masimo Co. has a 1-year low of $81.56 and a 1-year high of $130.00. The firm has a market capitalization of $6.88 billion, a price-to-earnings ratio of 52.42, a price-to-earnings-growth ratio of 2.70 and a beta of 1.07.
Several research firms have recently issued reports on MASI. Zacks Investment Research upgraded shares of Masimo from a “sell” rating to a “hold” rating in a report on Wednesday, January 23rd. Piper Jaffray Companies upgraded Masimo from a “neutral” rating to an “overweight” rating and set a $120.00 price objective for the company in a research report on Wednesday, December 19th. BidaskClub raised Masimo from a “hold” rating to a “buy” rating in a research note on Thursday, December 13th. Needham & Company LLC reissued a “buy” rating and issued a $139.00 price target on shares of Masimo in a report on Friday, February 1st. Finally, UBS Group started coverage on shares of Masimo in a research report on Tuesday, November 27th. They set a “buy” rating and a $137.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Masimo currently has an average rating of “Buy” and an average price target of $121.86.
Masimo Company Profile
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Featured Story: What are the most popular ETFs
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.